Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: Relation to progression following radical prostatectomy

Prostate

Volumn 34, Issue 1, 1998, Pages 29-33

  Sauvageot, Jurgita ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Prostate adenocarcinoma; PSA; PSAP; Radical prostatectomy

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY;

ACID PHOSPHATASE; ADENOCARCINOMA; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031983710     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980101)34:1<29::AID-PROS4>3.0.CO;2-F     Document Type: Article

References (17)

1. Epstein JI: PSAP and PSA as immunohistochemical markers. Urol Clin North Am 1993;20:757-770.
2. Jobsis AC, De Vries GP, Meijer AE, Ploem J: The immunohistochemical detection of prostatic acid phosphatase: Its possibilities and limitations in tumor histochemistry. Histochem J 1981;13: 961-973.
3. Nadji M, Tabei SZ, Castro A, Chu TM, Murphy GP, Wang MC, Morales AR: Prostatic specific antigen: A immunohistologic marker for prostatic neoplasms. Cancer 1981;48:1229-1232.
4. Keillor JS, Aterman KA: The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: A comparative study. J Urol 1986; 137:894-896.
5. Mahan DE, Bruce AW, Manley PN, Franchi L: Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy. J Urol 1979;124:488-491.
6. Pontes JE, Rose NR, Ercole C, Pierce JM Jr: Immunofluorescence for prostatic acid phosphatase: Clinical applications. J Urol 1981; 126:187-189.
7. 2 adenocarcinoma of the prostate: Prognostic implications. Hum Pathol 1984;15:853-859.
8. 2 prostatic carcinoma. Cancer 1992;69:511-519.
9. Hammond ME, Sause WT, Martz KL, Pilepich MV, Asbell SO, Rubin P, Myers RP, Farrow GM: Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma. Cancer 1989;63: 461-466.
10. Contractor H, Rüschoff J, Hanisch T, Ulshofer B, Neumann K, Schultze-Seeman W, Thomas C: Silver-stained structures in prostatic carcinoma: Evaluation of diagnostic and prognostic relevance by automated image analysis. Urol Int 1991;46:9-14.
11. Sakai H, Yogi Y, Minami Y, Yushita Y, Kanetake H, Saito Y: Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma. J Urol 1993;149:1020-1023.
12. Sakai H, Shiraishi K, Minami Y, Yushita Y, Kanetake H, Saito Y: Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma. Prostate 1991;19:265-272.
13. Epstein JI, Pizov G, Walsh PC: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993;71:3583-3593.
14. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fossa SD: DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/MO prostatic adenocarcinoma. Br J Urol 1995;75:26-32.
15. Bazinet M, Hamdy SM, Begin LR, Stephenson RA, Fair WR: Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer. Prostate 1992;20:311-326.
16. Zhou R, Hammond EH, Sause WT, Rubin P, Emami B, Pilepich MV, Asbell SD, Parker DL: Quantitation of prostate-specific acid phosphatase in prostate cancer: Reproducibility and correlation with subjective grade. Mod Pathol 1994;7:440-448.
17. Zhou R, Sause WT, Hammond EH, Rubin P, Perez C, Pilepich MV, Asbell SA, Parker DL: Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: A preliminary report of correlative studies on RTOG protocols 75-06m 77-06, and 83-07. Int J Radiat Oncol Biol Phys 1995;44:823-829.